MOTS-c has also been shown to relieve hyperglycemia and insulin resistance in gestational diabetes mellitus in a high fat diet/low-dose-streptozotocin mouse model131 and reduces lipid accumulation and fatty acid levels in livers of mice fed a normal diet.132. This evidence concerns the gene MT-RNR1 and Insulin resistance.